-
公开(公告)号:US20090048306A1
公开(公告)日:2009-02-19
申请号:US12114258
申请日:2008-05-02
申请人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Christa Stammen , Stephen Martin Denton , Melanie Susanne Glossop
发明人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Christa Stammen , Stephen Martin Denton , Melanie Susanne Glossop
IPC分类号: A61K31/4439 , C07D401/12 , A61P25/04
CPC分类号: C07D401/12 , C07D213/75 , C07D413/12
摘要: The present invention relates to compounds of the formula (I): and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,用于制备用于制备中间体的方法和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途。
-
公开(公告)号:US07368460B2
公开(公告)日:2008-05-06
申请号:US10678836
申请日:2003-10-03
CPC分类号: C07D451/04 , A61K9/2018 , A61K31/4196 , A61K31/46 , A61K2300/00
摘要: The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
摘要翻译: 本发明提供下式的化合物:其中R 1是任选被一个或多个氟原子取代的C 3-6环烷基,或C 1-6烷基, 任选被一个或多个氟原子取代的C 1 -C 6烷基或任意被一个或多个氟原子环取代的C 3-6环烷基甲基; 和R 2是任选被一个或多个氟原子取代的苯基,其药学上可接受的盐和溶剂合物,以及制备用于制备含有和/ ,这些化合物。
-
公开(公告)号:US20080132537A1
公开(公告)日:2008-06-05
申请号:US12023334
申请日:2008-01-31
CPC分类号: C07D451/04 , A61K9/2018 , A61K31/4196 , A61K31/46 , A61K2300/00
摘要: The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
摘要翻译: 本发明提供下式的化合物:其中R 1是任选被一个或多个氟原子取代的C 3-6环烷基或C 1-6 - 任选被一个或多个氟原子取代的C 1 -C 6烷基或任选被一个或多个氟原子环取代的C 3-6环烷基甲基; 和R 2是任选被一个或多个氟原子取代的苯基,其药学上可接受的盐和溶剂合物,以及制备用于制备含有和/或使用的组合物的组合物的中间体 ,这些化合物。
-
公开(公告)号:US06667314B2
公开(公告)日:2003-12-23
申请号:US09865950
申请日:2001-05-25
IPC分类号: A61K3146
CPC分类号: C07D451/04 , A61K9/2018 , A61K31/4196 , A61K31/46 , A61K2300/00
摘要: The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
摘要翻译: 本发明提供下式的化合物:其中R 1为任选被一个或多个氟原子取代的C 3-6环烷基,或任选被一个或多个氟原子取代的C 1-6烷基,或任选被C 3-6环烷基甲基任选的环 - 被一个或多个氟原子取代; 和R 2是任选被一个或多个氟原子取代的苯基,其药学上可接受的盐和溶剂合物,以及制备用于制备含这些化合物的组合物和用途的中间体的方法。
-
公开(公告)号:US07576097B2
公开(公告)日:2009-08-18
申请号:US12023334
申请日:2008-01-31
IPC分类号: A01N43/42 , C07D401/00 , C07D405/00 , C07D409/00
CPC分类号: C07D451/04 , A61K9/2018 , A61K31/4196 , A61K31/46 , A61K2300/00
摘要: The present invention provides compounds of the formula: wherein R1 is C3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C1-6 alkyl optionally substituted by one or more fluorine atoms, or C3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
-
公开(公告)号:US07217714B1
公开(公告)日:2007-05-15
申请号:US09451826
申请日:1999-11-30
申请人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
发明人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
IPC分类号: A61K31/535 , C07D401/00 , C07D215/16 , C07D217/00
CPC分类号: C07D451/02 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D413/04 , C07D413/14 , C07D451/04
摘要: Compounds of Formula 1 [Region α]−[Region β]−[Region γ]−[Region δ] (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.
摘要翻译: 式1的化合物<?in-line-formula description =“In-line Formulas”end =“lead”?> [R eg ion beta beta beta beta beta ] - [R ion ion gamma gamma]]]] <<<<<<<<<<<<“”“”“”“”“”“”“” α>可用作趋化因子活性的调节剂。 本发明还提供药物制剂和使用这些化合物的治疗方法。
-
公开(公告)号:US07041667B1
公开(公告)日:2006-05-09
申请号:US09452634
申请日:1999-12-01
申请人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
发明人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
IPC分类号: A61K31/535
CPC分类号: C07D451/02 , A61K45/06 , C07D207/14 , C07D211/58 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D451/04
摘要: Compounds of Formula 1 [Region α]—[Region β]—[Region γ]—[Region δ] (1) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.
摘要翻译: 式1的化合物<?in-line-formula description =“In-line Formulas”end =“lead”?> [R eg ion beta beta beta beta beta ] - [R ion ion gamma gamma]]]]] <<<<<<<<<<<<“”“”“”“”“”“”“”“”“ α>可用作趋化因子活性的调节剂。 本发明还提供药物制剂和使用这些化合物的治疗方法。
-
公开(公告)号:US06586430B1
公开(公告)日:2003-07-01
申请号:US09452578
申请日:1999-12-01
申请人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
发明人: Duncan Robert Armour , David Anthony Price , Blanda Luzia Christa Stammen , Anthony Wood , Manoussos Perros , Martin Paul Edwards
IPC分类号: C07D4504
CPC分类号: C07D451/02 , A61K45/06 , C07D207/14 , C07D211/58 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/12 , C07D405/14 , C07D413/04 , C07D413/14 , C07D451/04 , C07D513/08
摘要: Compounds of Formula 1 [Region &agr;]-[Region &bgr;]-[Region &ggr;]-[Region &dgr;] (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.
摘要翻译: 式1的化合物,其可用作趋化因子活性的调节剂。 本发明还提供药物制剂和使用这些化合物的治疗方法。
-
-
-
-
-
-
-